Larry H. Stanker

Papers

Total Citations

H-Index

About

Dr. Larry H. Stanker is a distinguished immunologist and toxin researcher whose work has profoundly advanced the detection and understanding of botulinum neurotoxins (BoNTs). His primary research focuses on developing innovative antibody-based detection technologies for high-risk biological agents, with a particular emphasis on BoNT—a substance of dual concern due to its potential as a biological warfare agent and its therapeutic use in neurological disorders. Dr. Stanker’s most cited work, the 2012 review "Botulinum neurotoxin: Where are we with detection technologies?" (64 citations), critically evaluates the landscape of BoNT detection methods, highlighting the urgent need for sensitive, rapid, and field-deployable assays. His contributions include pioneering monoclonal antibody development and immunoassay platforms that enhance both safety and clinical application. With a career spanning decades at the USDA and Lawrence Livermore National Laboratory, Dr. Stanker’s research has been instrumental in bridging the gap between basic immunology and practical biodefense, earning him recognition as a key figure in toxin detection. His work continues to guide students and researchers in navigating the complexities of neurotoxin analysis and public health preparedness.